Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09221-3
Abstract: A 56-year-old man presented with a 6 month history of dysarthrophonia, orofacial dyskinesia and chorea of both hands. His wife reported snoring, day sleepiness, insomnia and limb movements during sleep. The patient and his wife… read more here.
Keywords: iglon5 encephalopathy; iglon5; treatment; impairment ... See more keywords